Innovent's $100M deal signals how biotech is ready to explode in China
26 January 2015
China biotech Innovent's recent success in raising $100 million in venture capital to help it build a pipeline of biosimilars could be a signal of how the industry may be set to explode in a country about to invest $6.45 billion in startups.
Booming biotechs bank $2.7B in follow-on cash
26 January 2015
Much of the focus in biotech's recent boom has been on the ease with which companies are making their way onto Wall Street. And, over the past week, a host of drug developers illustrated the benefits of being a publicly traded company, raising roughly $2.7 billion in follow-on offerings to bankroll R&D and potential acquisitions.
Challenger says 2015 a year to send out your resume, pharma folks
26 January 2015
EU IPO figures for 2014 dwarf previous 5 years combined
26 January 2015
The biotech IPO boom was slow to cross the Atlantic. From 2009 to 2013, European biotechs raised €303 million ($350 million) in home-turf IPOs, around 10% of the amount their U.S. peers pocketed in just one of those years. The situation improved dramatically in 2014, though.
Over $500 Billion Invested in R&D by PhRMA Member Companies Since 2000
26 January 2015
Developing innovative, lifesaving medicines for patients is the sole focus of the biopharmaceutical industry. PhRMA member companies invested more than $50 billion in research and development (R&D) in 2013 and over half a trillion dollars since 2000. This represents the vast majority of all biopharmaceutical R&D spending – both private and government – in the United States. In fact, the pharmaceutical sector accounts for approximately 20 percent of all domestic R&D funding by U.S. businesses, supporting millions of jobs across the country.
Medical investment declining in U.S., rising in China
23 January 2015
With the global center of gravity shifting eastward and the world's most populous region increasingly wealthy, it should come as no surprise that Asia is gaining momentum in medical research. This advancement is taking place while the leadership role of the U.S. transforms into an important player in a multipolar research world.
China's Innovent banks $100M to cash in on the biosimilar boom
23 January 2015
Innovent Biologics has raised $100 million in venture cash in hopes of becoming the premier maker of biotech drugs in its native China, advancing a pipeline of biosimilars and proprietary treatments.
New international standard to improve safety of medicines
23 January 2015
The European Medicines Agency (EMA) has published a guide to support the implementation of a new international standard for the safety monitoring of medicines in the European Union (EU). The so-called ISO ICSR standard improves the reporting of suspected side effects of medicines in Individual Case Safety Reports (ICSRs). The use of the new international standard will take effect on 1 July 2016.
Med tech IPO mania: 6 IPOs ready to raise $324M
22 January 2015
At least a half-dozen med tech companies are ready for an IPO in the coming weeks. Already, they have either set IPO terms or have launched on to an IPO road show to sell investors. The three that have set rough IPO dates all have done so for the end of January.
Top 10 med tech market movers in 2014
22 January 2015
A rising tide lifts all boats--that might be the most oft-repeated cliché to sum up market sentiment in the life sciences for the past few years. Biotech performance has been very, very good for three years, and med tech performance, while nowhere near as stellar, has been on its own upward trajectory as investors look for a safer way to make money in healthcare.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024